Work

Abstract PS3-11-19: Guiding the Axilla: Combining SUVmax and Monocytes to Predict Response to Neoadjuvant Therapy in HER2 positive Breast Cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps3-11-19

Authors: L. Raimondi, M. Cuzzocrea, C. Oliva, N. Peradze, Y. Harder, D. Schmauss, R. Graffeo Galbiati, L. Rossi

Institutions: Ente Ospedaliero Cantonale, Istituto Imaging della Svizzera Italiana, European Institute of Oncology, Ospedale regionale di Lugano, Istituto Oncologico della Svizzera Italiana

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129256737

Cites:

Cited by:

Related to: